These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 10411554

  • 1. Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK(2) receptor.
    Renzetti AR, Catalioto RM, Criscuoli M, Cucchi P, Ferrer C, Giolitti A, Guelfi M, Rotondaro L, Warner FJ, Maggi CA.
    J Pharmacol Exp Ther; 1999 Aug; 290(2):487-95. PubMed ID: 10411554
    [Abstract] [Full Text] [Related]

  • 2. Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor.
    Meini S, Catalani C, Bellucci F, Cucchi P, Giuliani S, Zappitelli S, Rotondaro L, Pasqui F, Guidi A, Altamura M, Giolitti A, Maggi CA.
    Eur J Pharmacol; 2005 Jun 01; 516(2):104-11. PubMed ID: 15925360
    [Abstract] [Full Text] [Related]

  • 3. Mutagenesis at the human tachykinin NK(2) receptor to define the binding site of a novel class of antagonists.
    Meini S, Bellucci F, Catalani C, Cucchi P, Patacchini R, Rotondaro L, Altamura M, Giuliani S, Giolitti A, Maggi CA.
    Eur J Pharmacol; 2004 Mar 19; 488(1-3):61-9. PubMed ID: 15044036
    [Abstract] [Full Text] [Related]

  • 4. Molecular determinants of peptide and nonpeptide NK-2 receptor antagonists binding sites of the human tachykinin NK-2 receptor by site-directed mutagenesis.
    Giolitti A, Cucchi P, Renzetti AR, Rotondaro L, Zappitelli S, Maggi CA.
    Neuropharmacology; 2000 Jun 08; 39(8):1422-9. PubMed ID: 10818258
    [Abstract] [Full Text] [Related]

  • 5. Characterization of [3H]MEN 11420, a novel glycosylated peptide antagonist radioligand of the tachykinin NK2 receptor.
    Renzetti AR, Catalioto RM, Criscuoli M, Cucchi P, Lippi A, Guelfi M, Quartara L, Maggi CA.
    Biochem Biophys Res Commun; 1998 Jul 09; 248(1):78-82. PubMed ID: 9675089
    [Abstract] [Full Text] [Related]

  • 6. Tachykinin NK2 receptors: characterization in the rat small intestine by the use of a peptide agonist and a nonpeptide antagonist as radioligands.
    Renzetti AR, Criscuoli M, Maggi CA.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul 09; 356(1):139-44. PubMed ID: 9228201
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors.
    Jensen CJ, Gerard NP, Schwartz TW, Gether U.
    Mol Pharmacol; 1994 Feb 09; 45(2):294-9. PubMed ID: 7509441
    [Abstract] [Full Text] [Related]

  • 9. Isolation and characterization of neurokinin A receptor cDNAs from guinea-pig lung and rabbit pulmonary artery.
    Aharony D, Little J, Thomas C, Powell S, Downey-Jones M, Graham A.
    J Recept Res; 1994 Dec 09; 14(6-8):399-421. PubMed ID: 7877137
    [Abstract] [Full Text] [Related]

  • 10. Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA.
    Aharony D, Little J, Thomas C, Powell S, Berry D, Graham A.
    Mol Pharmacol; 1994 Jan 09; 45(1):9-19. PubMed ID: 8302285
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological evaluation of alpha and beta human tachykinin NK(2) receptor splice variants expressed in CHO cells.
    Bellucci F, Meini S, Catalioto RM, Catalani C, Giuliani S, Quartara L, Giolitti A, Faiella A, Rotondaro L, Candenas ML, Pinto FM, Maggi CA.
    Eur J Pharmacol; 2004 Sep 24; 499(3):229-38. PubMed ID: 15381044
    [Abstract] [Full Text] [Related]

  • 12. Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors.
    Gether U, Yokota Y, Emonds-Alt X, Brelière JC, Lowe JA, Snider RM, Nakanishi S, Schwartz TW.
    Proc Natl Acad Sci U S A; 1993 Jul 01; 90(13):6194-8. PubMed ID: 7687062
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MEN 10,627, a novel polycyclic peptide antagonist of tachykinin NK2 receptors.
    Maggi CA, Astolfi M, Giuliani S, Goso C, Manzini S, Meini S, Patacchini R, Pavone V, Pedone C, Quartara L.
    J Pharmacol Exp Ther; 1994 Dec 01; 271(3):1489-500. PubMed ID: 7996462
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacological characterization of cloned human NK-2 (neurokinin A) receptor expressed in a baculovirus/Sf-21 insect cell system.
    Aharony D, Little J, Powell S, Hopkins B, Bundell KR, McPheat WL, Gordon RD, Hassall G, Hockney R, Griffin R.
    Mol Pharmacol; 1993 Aug 01; 44(2):356-63. PubMed ID: 8394992
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the [125I]-neurokinin A binding site in the circular muscle of human colon.
    Warner FJ, Comis A, Miller RC, Burcher E.
    Br J Pharmacol; 1999 Jul 01; 127(5):1105-10. PubMed ID: 10455255
    [Abstract] [Full Text] [Related]

  • 19. Independent coupling of the human tachykinin NK2 receptor to phospholipases C and A2 in transfected Chinese hamster ovary cells.
    Catalioto RM, Cucchi P, Renzetti AR, Criscuoli M, Maggi CA.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct 01; 358(4):395-403. PubMed ID: 9826060
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.